These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35261664)

  • 21. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis of COVID-19: Red Cell Distribution Width, Platelet Distribution Width, and C-Reactive Protein.
    Bommenahalli Gowda S; Gosavi S; Ananda Rao A; Shastry S; Raj SC; Menon S; Suresh A; Sharma A
    Cureus; 2021 Feb; 13(2):e13078. PubMed ID: 33680618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory Biomarkers Associated with In-Hospital Mortality in Critical COVID-19 Patients.
    Pál K; Molnar AA; Huțanu A; Szederjesi J; Branea I; Timár Á; Dobreanu M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019.
    Zhu Z; Cai T; Fan L; Lou K; Hua X; Huang Z; Gao G
    Int J Infect Dis; 2020 Jun; 95():332-339. PubMed ID: 32334118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and Inflammatory Profile of COVID-19 Infection at a Tertiary Care Centre in Northern Part of Tamil Nadu - A Retrospective Study.
    Shanmukham B; Srivijayan A; Venugopal S; Ravikoti S; Kaliappan A; Gaur A; Geetha J; Sakthivadivel V; Balan Y; Sundaramurthy R
    Cureus; 2022 Oct; 14(10):e30139. PubMed ID: 36381779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in plasma interleukin-33 concentration in sepsis and its correlation with seriousness of sepsis].
    Chang D; Jia J; Zang B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):138-42. PubMed ID: 25665614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Composite Study of Coagulation Milieu in Covid-19: Experience from a Tertiary Care Centre from India.
    Bohra GK; Purohit A; Kumar D; Garg MK; Midha NK; Manglia R; Jain K; Didel S; Nag V; Sharma P; Sharma A; Bhatia P; Misra S
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(3):185-195. PubMed ID: 34852756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan.
    Pya Y; Bekbossynova M; Gaipov A; Lesbekov T; Kapyshev T; Kuanyshbek A; Tauekelova A; Litvinova L; Sailybayeva A; Vakhrushev I; Sarria-Santamera A
    PLoS One; 2021; 16(12):e0261272. PubMed ID: 34936681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An analysis of hematological, coagulation and biochemical markers in COVID-19 disease and their association with clinical severity and mortality: an Indian outlook.
    Pujani M; Raychaudhuri S; Singh M; Kaur H; Agarwal S; Jain M; Chandoke RK; Singh K; Sidam D; Chauhan V
    Am J Blood Res; 2021; 11(6):580-591. PubMed ID: 35103112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
    Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
    J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complicated Acute Cholecystitis: The Role of C-Reactive Protein and Neutrophil-Lymphocyte Ratio as Predictive Markers of Severity.
    Mahmood F; Akingboye A; Malam Y; Thakkar M; Jambulingam P
    Cureus; 2021 Feb; 13(2):e13592. PubMed ID: 33796428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early increases in serum FGF21 levels predict mortality of septic patients.
    Li X; Zhu Z; Zhou T; Cao X; Lu T; Liang Y; He J; Liu C; Dou Z; Shen B
    Cytokine; 2018 Nov; 111():428-433. PubMed ID: 29861384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The predictive value of serum amyloid A and C-reactive protein levels for the severity of coronavirus disease 2019.
    Chen M; Wu Y; Jia W; Yin M; Hu Z; Wang R; Li W; Wang G
    Am J Transl Res; 2020; 12(8):4569-4575. PubMed ID: 32913530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Predictive Ability of Epidemiological Factors, Inflammatory Biomarkers, and CT Severity Score for Mortality in COVID-19.
    Jain A; Kasliwal R; Jain SS; Gupta D; Jain R; Jain A; Jain R
    J Assoc Physicians India; 2021 Aug; 69(8):11-12. PubMed ID: 34472808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019.
    Luo X; Zhou W; Yan X; Guo T; Wang B; Xia H; Ye L; Xiong J; Jiang Z; Liu Y; Zhang B; Yang W
    Clin Infect Dis; 2020 Nov; 71(16):2174-2179. PubMed ID: 32445579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 38. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
    Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
    Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of mortality among hospitalized COVID-19 patients and risk score formulation for prioritizing tertiary care-An experience from South India.
    Gopalan N; Senthil S; Prabakar NL; Senguttuvan T; Bhaskar A; Jagannathan M; Sivaraman R; Ramasamy J; Chinnaiyan P; Arumugam V; Getrude B; Sakthivel G; Srinivasalu VA; Rajendran D; Nadukkandiyil A; Ravi V; Hifzour Rahamane SN; Athur Paramasivam N; Manoharan T; Theyagarajan M; Chadha VK; Natrajan M; Dhanaraj B; Murhekar MV; Ramalingam SM; Chandrasekaran P
    PLoS One; 2022; 17(2):e0263471. PubMed ID: 35113971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
    J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.